Inhibitor Therapeutics, Inc. Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Inhibitor Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Inhibitor Therapeutics, Inc. for February 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2018 | HPPI | HedgePath Pharmace ... | Cross Stefan | Director | Sell | P | 162,660.00 | 600,000 | 97,596,000,000 | 0 | 600 K to 0 (-100.00 %) |
| Feb 12 2018 | HPPI | HedgePath Pharmace ... | Mayne Pharma Ventures Pty Ltd | 10% Owner | Buy | P | 162,660.00 | 600,000 | 97,596,000,000 | 198,106,132 | 197.5 M to 198.1 M (+0.30 %) |